Malabsorption News

Prometheus Laboratories has announced the launch of a new test called IBcause that simultaneously evaluates 20 stool and serum measures to help diagnose many common causes of persistent diarrhea.

RP-G28, a non-digestible oligosaccharide designed to stimulate the gut microbiota to metabolize lactose, improved abdominal symptoms in patients with lactose intolerance in a phase 2b/3 trial, the manufacturer announced.

There is a lack of current evidence to determine the balance of benefits and harms of screening for celiac disease in all asymptomatic adults, adolescents and children, according to a report issued by the U.S. Preventive Services Task Force.

A new study revealed that the prevalence of celiac disease and gluten-related disorders is higher in the northern latitudes of the U.S. compared with the south.

Latiglutenase did not improve histologic and symptomatic measures of disease activity in patients with symptomatic celiac disease compared with placebo in a phase 2 study.

Frequent consumption of gluten may be associated with a lower risk for type 2 diabetes, according to research presented at the American Heart Association’s Epidemiology and Prevention / Lifestyle and Cardiometabolic Health 2017 Scientific Sessions in Portland, Oregon.

Most patients with celiac disease who were symptomatic despite adhering to a gluten free diet did not have active disease based on analysis of follow-up biopsies in a recent study, suggesting that symptoms were poor predictors of ongoing mucosal injury.

Individuals on a gluten-free diet may be exposing themselves to higher levels of arsenic and mercury, according to new research.

Adults with type 1 diabetes and celiac disease do not report worse quality of life compared with adults with type 1 diabetes or celiac disease alone or those without either disease, recent data indicate.

Patients with lactose intolerance who received RP-G28, a high purity short-chain galactooligosaccharide prebiotic, experienced clinical improvements that correlated with significant alterations in their gut microbiome, according to the results of a randomized controlled trial.